Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R John Simes

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
American Journal of Epidemiology|July 24, 2007
Biases in the identification of risk factor thresholds and J-curvesIan C Marschner, R John Simes, Anthony Keech
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancerShom Goel, R John Simes, Jane M Beith
Annals of Internal Medicine|June 7, 2006
When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?Sarah J Lord, Les Irwig, R John Simes
The Medical Journal of Australia|September 12, 2022
Changes to design and analysis elements of research plans during randomised controlled trials in AustraliaXanthi Coskinas, R John Simes, Andrew J Martin
International Journal of Technology Assessment in Health Care|January 11, 2012
Linking the evidence: intermediate outcomes in medical test assessmentsLukas P Staub, Suzanne Dyer, Sarah J Lord, et al.
The Medical Journal of Australia|June 3, 2009
Molecular biomarkers to individualise treatment: assessing the evidenceChee K Lee, Sarah J Lord, Alan S Coates, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancerPeter S Grimison, R John Simes, H Malcolm Hudson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Deriving a patient-based utility index from a cancer-specific quality of life questionnairePeter S Grimison, R John Simes, H Malcolm Hudson, et al.
Australian and New Zealand Journal of Public Health|January 7, 2004
The benefits and costs of tamoxifen for breast cancer preventionSimon D Eckermann, Andrew J Martin, Martin R Stockler, et al.
Annals of Internal Medicine|May 7, 2008
Monitoring cholesterol levels: measurement error or true change?Paul P Glasziou, Les Irwig, Stephane Heritier, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
American Journal of Epidemiology|July 24, 2007
Biases in the identification of risk factor thresholds and J-curvesIan C Marschner, R John Simes, Anthony Keech
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancerShom Goel, R John Simes, Jane M Beith
Annals of Internal Medicine|June 7, 2006
When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?Sarah J Lord, Les Irwig, R John Simes
The Medical Journal of Australia|September 12, 2022
Changes to design and analysis elements of research plans during randomised controlled trials in AustraliaXanthi Coskinas, R John Simes, Andrew J Martin
International Journal of Technology Assessment in Health Care|January 11, 2012
Linking the evidence: intermediate outcomes in medical test assessmentsLukas P Staub, Suzanne Dyer, Sarah J Lord, et al.
The Medical Journal of Australia|June 3, 2009
Molecular biomarkers to individualise treatment: assessing the evidenceChee K Lee, Sarah J Lord, Alan S Coates, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 4, 2009
Preliminary validation of an optimally weighted patient-based utility index by application to randomized trials in breast cancerPeter S Grimison, R John Simes, H Malcolm Hudson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Deriving a patient-based utility index from a cancer-specific quality of life questionnairePeter S Grimison, R John Simes, H Malcolm Hudson, et al.
Australian and New Zealand Journal of Public Health|January 7, 2004
The benefits and costs of tamoxifen for breast cancer preventionSimon D Eckermann, Andrew J Martin, Martin R Stockler, et al.
Annals of Internal Medicine|May 7, 2008
Monitoring cholesterol levels: measurement error or true change?Paul P Glasziou, Les Irwig, Stephane Heritier, et al.
Pageof 8